EP3445179A4 - Cannabis-enriched enzymatically treated therapeutic composition - Google Patents
Cannabis-enriched enzymatically treated therapeutic composition Download PDFInfo
- Publication number
- EP3445179A4 EP3445179A4 EP17785542.6A EP17785542A EP3445179A4 EP 3445179 A4 EP3445179 A4 EP 3445179A4 EP 17785542 A EP17785542 A EP 17785542A EP 3445179 A4 EP3445179 A4 EP 3445179A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- cannabis
- enriched
- therapeutic composition
- enzymatically treated
- treated therapeutic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000218236 Cannabis Species 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662324594P | 2016-04-19 | 2016-04-19 | |
| US201662324577P | 2016-04-19 | 2016-04-19 | |
| PCT/IB2017/052214 WO2017182950A1 (en) | 2016-04-19 | 2017-04-18 | Cannabis-enriched enzymatically treated therapeutic composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP3445179A1 EP3445179A1 (en) | 2019-02-27 |
| EP3445179A4 true EP3445179A4 (en) | 2020-07-22 |
Family
ID=60116671
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP17785542.6A Pending EP3445179A4 (en) | 2016-04-19 | 2017-04-18 | Cannabis-enriched enzymatically treated therapeutic composition |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US11839601B2 (en) |
| EP (1) | EP3445179A4 (en) |
| CA (1) | CA3021144C (en) |
| IL (1) | IL262419B1 (en) |
| WO (1) | WO2017182950A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10239808B1 (en) | 2016-12-07 | 2019-03-26 | Canopy Holdings, LLC | Cannabis extracts |
| US10213390B1 (en) | 2017-09-28 | 2019-02-26 | Zynerba Pharmaceuticals, Inc. | Treatment of fragile X syndrome with cannabidiol |
| EP3703672A4 (en) * | 2017-10-30 | 2021-12-01 | Endocanna Health, Inc. | Cannabinoid formulations |
| CA3081151A1 (en) * | 2017-10-31 | 2019-05-09 | Buzzelet Development And Technologies Ltd | New cannabis compositions and industrial methods for production thereof |
| EP3716945A4 (en) * | 2017-11-30 | 2021-04-07 | Canopy Growth Corporation | Liquid dosage forms, methods of making and use |
| WO2019152736A1 (en) | 2018-01-31 | 2019-08-08 | Canopy Holdings, LLC | Hemp powder |
| EP3864000A4 (en) | 2018-10-10 | 2022-08-10 | Treehouse Biosciences, Inc. | Synthesis of cannabigerol |
| US20200115663A1 (en) * | 2018-10-16 | 2020-04-16 | Golden Spice Liquors LLC | Beverage compositions and methods of making and using the same |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5385827A (en) * | 1989-09-20 | 1995-01-31 | Clark; John R. | Method of geochemical prospecting |
| JP2893953B2 (en) * | 1992-10-27 | 1999-05-24 | 藤沢薬品工業株式会社 | Bifidobacterium growth promoter |
| CN1039773C (en) | 1993-10-14 | 1998-09-16 | 马忠杰 | Bee product with high content of organic trace element and its making method |
| NL1013943C2 (en) | 1999-12-23 | 2001-06-26 | Triticum Holding B V | Food for the relief of occasional heartburn, reflux complaints (gastroesophageal reflux complaints) and gastrointestinal complaints based on honey, as well as a pressed product containing such a foodstuff. |
| US20090202613A1 (en) * | 2008-02-11 | 2009-08-13 | Tabatchnick Fine Foods, Inc. | Nutritionally Enhanced Therapeutic Preventative Food Supplement and Method of Making Same |
| US8445034B1 (en) * | 2010-11-02 | 2013-05-21 | Albert L Coles, Jr. | Systems and methods for producing organic cannabis tincture |
| US8642645B2 (en) * | 2011-05-20 | 2014-02-04 | Brooks Kelly Research, LLC. | Pharmaceutical composition comprising Cannabinoids |
| US20140199266A1 (en) | 2013-01-14 | 2014-07-17 | Lost Creek Consulting, Llc | Honey nasal rinse |
| JP2016537412A (en) * | 2013-10-31 | 2016-12-01 | フル スペクトラム ラボラトリーズ，エルティーディー． | Terpenes and cannabinoid formulations |
| AU2016295728B2 (en) * | 2015-07-22 | 2020-07-23 | Phytopharma International Ltd. | Bee-ingestible compositions, methods of using same for producing honey and honey produced thereby |
| US10617722B2 (en) | 2015-10-31 | 2020-04-14 | Canna-B Cure Ltd | Honey-cannabinoid therapeutic composition |
-
2017
- 2017-04-18 CA CA3021144A patent/CA3021144C/en active Active
- 2017-04-18 US US16/094,642 patent/US11839601B2/en active Active
- 2017-04-18 IL IL262419A patent/IL262419B1/en unknown
- 2017-04-18 EP EP17785542.6A patent/EP3445179A4/en active Pending
- 2017-04-18 WO PCT/IB2017/052214 patent/WO2017182950A1/en active Application Filing
Non-Patent Citations (1)
| Title |
|---|
| No Search * |
Also Published As
| Publication number | Publication date |
|---|---|
| CA3021144A1 (en) | 2017-10-26 |
| US11839601B2 (en) | 2023-12-12 |
| EP3445179A1 (en) | 2019-02-27 |
| WO2017182950A1 (en) | 2017-10-26 |
| US20190105298A1 (en) | 2019-04-11 |
| IL262419A (en) | 2018-12-31 |
| CA3021144C (en) | 2024-04-09 |
| IL262419B1 (en) | 2024-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3263132A4 (en) | Composition for treating il-6-related diseases | |
| EP3601536A4 (en) | Treatment methods | |
| EP3349751A4 (en) | Cenicriviroc combination therapy for the treatment of fibrosis | |
| EP3256113A4 (en) | Treatment of hypoparathyroidism | |
| EP3252124A4 (en) | Surface treatment agent | |
| EP3368033A4 (en) | Honey-cannabinoid therapeutic composition | |
| EP3409744A4 (en) | Surface treatment agent | |
| EP3445179A4 (en) | Cannabis-enriched enzymatically treated therapeutic composition | |
| EP3302439A4 (en) | Therapeutic composition | |
| EP3389645A4 (en) | Combinations for the treatment of cancer | |
| EP3564335A4 (en) | Surface treatment agent | |
| EP3705545A4 (en) | Surface treatment composition | |
| SI3524255T1 (en) | Composition for the treatment of acne | |
| EP3431566A4 (en) | Surface treatment agent | |
| EP3362091A4 (en) | Combination treatment | |
| EP3344256A4 (en) | Compositions for the treatment of joints | |
| EP3288636A4 (en) | Compositions for the treatment of epistaxis | |
| EP3386593A4 (en) | Immunomodulating composition for treatment | |
| EP3341006A4 (en) | Compositions and methods for the treatment of neurodamage | |
| EP3309165A4 (en) | Surface treatment agent | |
| EP3256124A4 (en) | Cenicriviroc for the treatment of fibrosis | |
| EP3354284A4 (en) | Composition for treating pain | |
| EP3309164A4 (en) | Surface treatment agent | |
| EP3294339A4 (en) | Methods and compositions for the treatment of arthritis | |
| EP3432884A4 (en) | Combination for treating pain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20181113 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| AX | Request for extension of the european patent |
Extension state: BA ME |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: CANNA-B CURE LTD |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Free format text: PREVIOUS MAIN CLASS: A23L0021000000 Ipc: A61K0031050000 |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20200623 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: A23L 21/25 20160101ALI20200617BHEP Ipc: A61K 31/191 20060101ALI20200617BHEP Ipc: A61K 31/05 20060101AFI20200617BHEP Ipc: A23L 33/125 20160101ALI20200617BHEP Ipc: A23L 33/105 20160101ALI20200617BHEP Ipc: A23L 33/10 20160101ALI20200617BHEP Ipc: A61P 25/28 20060101ALI20200617BHEP Ipc: A61P 25/22 20060101ALI20200617BHEP Ipc: A61K 31/352 20060101ALI20200617BHEP Ipc: A23L 21/00 20160101ALI20200617BHEP Ipc: A61P 25/08 20060101ALI20200617BHEP Ipc: A61K 31/7004 20060101ALI20200617BHEP Ipc: A61P 25/16 20060101ALI20200617BHEP Ipc: A61P 1/00 20060101ALI20200617BHEP |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
| 17Q | First examination report despatched |
Effective date: 20230406 |